Login

Introducing Bertrandt: Explore Our Story | Gerrit Schmidt - President - Bertrandt 00:10:00

Share On Facebook Share On Twitter

Gerrit Schmidt is the President of Bertrandt

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:00:00
Alan Beasley, CEO, Hydroponics Company Ltd
00:10:00
"Designing the Workplace of Tomorrow: Insights from Simi Dubb, Global Head of Talent Management at Fidelity International"
00:10:00
Gordon Haskett analyst John Inch, holding a neutral rating on GE with a $7 price target, expresses skepticism despite the company's cash flow beat.
00:10:00
Addex Therapeutics' Advancements in Allosteric Modulation and Collaborative Ventures in CNS Pharmaceuticals |Tim DyerCo , CEO, Addex Therapeutics Ltd.
00:10:00
Marco's Insights on the Booming Latino Economy and Investment Strategies
00:10:00
Dr. Clarence Moniba's Journey and Liberia's Historical Context|Clarence K. Moniba
00:10:00
Big Data and AI: Navigating Risks and Opportunities in Infrastructure Software
00:10:00
Revolutionary Solar Tracking Technology Sparks Market Expansion via Strategic IPO | Louis Maurice, CEO, Groupe Okwind SA.
00:10:00
Peterson We Services Discusses Market Volatility and Long-Term Investment Strategies
00:10:00
Max Tuesley Provides Update on Culpeo Minerals’ Drilling Progress at Resourcing Tomorrow 2022 | Max Tuesley, Managing Director , Culpeo Mineral Plc.
00:10:00
Verb Technology CEO Rory Cutaia discusses the company's interactive video-based solutions with Steve Darling from Proactive.
00:10:00
Emmerson PLC's Hayden Locke Highlights Development and Funding Progress for World-Class Khemisset Potash Project at Cape Town Mining Conference

© 2017 - Neuhu+